Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copenhagen Head Injury Ciclosporin (CHIC) Study
2012-000756-34Phase 2Terminated
- Sponsor
- Abliva AB
- Start
- Sep 2012
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of NeuroSTAT in traumatic brain injury (TBI) (2 arms), sponsored by Abliva AB. Started Sep 2012; status: terminated.
02
Drugs
NeuroSTAT
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2012-000756-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000756-34.